Quantitative Immunohistochemical Expression of GP88 in Invasive Ductal Carcinoma (IDC) of Human Breast Cancer
Preprint
- 5 October 2020
- preprint
- Published by Springer Nature in Research Square
Abstract
Background: Progranulin or acrogranin is an 88-kDa glycoprotein identified by a biological screen for protein targets associated with high tumorigenicity. This work was aimed to investigate the digital expression of GP88, and HER2/neu as a predictive biomarker in human invasive ductal carcinoma (IDC) versus benign tumors and normal breast tissues, as well as, its correlation with different pathological parameters.Methods: The immunohistochemical avidin-biotin complex protocol of the paraffin section was used to detect the expression of GP88 and HER2/neu in IDC of 60 patients, 30 benign, and ten normal breast tissues. Results: the study showed a high expression of GP88 in IDC comparing to normal and benign breast tissues. A higher significant statistical correlation between the expression of GP88 and large tumor size, tumor grade, and lymph node metastasis (LNM). While a negative statistical correlation was noticed between the expression of GP88 and ER, PR, and HER2/neu status.Conclusion: It could be concluded that GP88 glycoprotein may be a valuable predictive and therapeutic marker in human IDC patients.Keywords
All Related Versions
This publication has 34 references indexed in Scilit:
- Association of Serum Progranulin Levels With Disease Progression, Therapy Response and Survival in Patients With Metastatic Breast CancerClinical Breast Cancer, 2020
- Progranulin and its biological effects in cancerMedical Oncology, 2017
- Progranulin as a predictive factor of response to chemotherapy in advanced biliary tract carcinomaCancer Chemotherapy and Pharmacology, 2016
- GP88 (progranulin): a novel tissue and circulating biomarker for non–small cell lung carcinomaHuman Pathology, 2014
- Circulating plasma DNA and DNA integrity in breast cancer patients undergoing neoadjuvant chemotherapyClinica Chimica Acta, 2013
- Progranulin expression in breast cancer with different intrinsic subtypesPathology - Research and Practice, 2012
- Progranulin: A growth factor, a novel TNFR ligand and a drug targetPharmacology & Therapeutics, 2012
- Progranulin is a potential prognostic biomarker in advanced epithelial ovarian cancersGynecologic Oncology, 2011
- The granulin gene family: from cancer to dementiaBioEssays, 2009
- Granulin-epithelin precursor as a therapeutic target for hepatocellular carcinomaHepatology, 2008